Alatau: Government Approves $71 Million Biopharma Plant

Investment & companiesGrowing4 Sources

Published 9 Nov 2026 · last updated 11 Nov 2026 · 25 May 2026 – 26 May 2026

The Kazakh government has approved the construction of a full-cycle biopharmaceutical complex in the Alatau Special Economic Zone. The investment project by Steppe Pharmaceuticals amounts to 32.5 billion tenge (approx. $71 million). Completion is scheduled for 2031, with full capacity expected in 2032.

District: Growing (derived from the type of project)

Key facts

• Investment volume: 32.5 billion tenge (approx. $71 million).
• Production of 20 types of medicines, including for cancer and rare diseases.
• Construction completion by 2031, full capacity in 2032.
• Creation of approximately 60 jobs.
• Approved by Prime Minister Olzhas Bektenov.

All sources (4)

1. В Алматинской области на территории СЭЗ «Алатау» построят фармзаводVlast.kz (Telegram) · 25 May 2026 · RU
2. 投资325亿坚戈：阿拉木图州将建设生物制药综合体哈通社 · 25 May 2026 · ZH
3. Kazakhstan approves 32.5 billion tenge biopharmaceutical plant in Alatau SEZinterfax.kz · 25 May 2026 · EN
4. Kazakhstan Approves $71 Million Biopharmaceutical Plant in Almaty RegionThe Astana Times · 26 May 2026 · EN